Motilal Oswal Subsidiary MOAMC Receives PFRDA Approval for NPS Pension Fund Sponsor
Motilal Oswal Asset Management Company (MOAMC) has secured a Letter of Appointment from the PFRDA to serve as a Sponsor of a Pension Fund under the National Pension System. This regulatory milestone allows the company to establish a dedicated entity for managing retirement assets, significantly broadening its presence in the pension management sector.
Privi Speciality Chemicals Receives NSE No Objection for Amalgamation Scheme
Privi Speciality Chemicals has cleared a major regulatory milestone by obtaining a 'no objection' observation letter from the National Stock Exchange of India for its proposed merger. The scheme involves integrating Privi Fine Sciences and Privi Biotechnologies into the parent entity to streamline operations and enhance group synergies.
Steel Exchange India Secures 5-Year MES Approval Renewal for SIMHADRI TMT Bars
Steel Exchange India Limited has secured a five-year renewal of approval from the Military Engineer Services (MES), Ministry of Defence, for its SIMHADRI TMT brand. This authorization ensures the company remains an approved supplier for critical government infrastructure and defense projects across India.
Auro Laboratories Secures EDQM Approval for Metformin Hydrochloride Facility at Tarapur
Auro Laboratories has received a formal Attestation of Inspection from the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its MIDC Tarapur facility. This regulatory milestone confirms the site's compliance with European Union Good Manufacturing Practice (GMP) standards for the production of Metformin Hydrochloride.
Auro Laboratories Secures Swissmedic GMP Compliance for Tarapur Plant; Revenue Up 207%
Auro Laboratories Ltd has secured a Certificate of GMP Compliance from Swissmedic for its manufacturing facility in Tarapur, Maharashtra. This approval validates the plant's adherence to international quality standards under the EU-Switzerland Mutual Recognition Agreement, facilitating entry into regulated European markets.